JP2004527452A5 - - Google Patents

Info

Publication number

JP2004527452A5

JP2004527452A5 JP2002504307A JP2002504307A JP2004527452A5 JP 2004527452 A5 JP2004527452 A5 JP 2004527452A5 JP 2002504307 A JP2002504307 A JP 2002504307A JP 2002504307 A JP2002504307 A JP 2002504307A JP 2004527452 A5 JP2004527452 A5 JP 2004527452A5

Authority

JP

Japan

Prior art keywords

thrombomodulin

analog

modified

native

seq

Prior art date

2001-06-20

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Granted

Links

• Espacenet
• Global Dossier
• Discuss

• 102100026966 Thrombomodulin Human genes 0.000 description 62
• 108010079274 Thrombomodulin Proteins 0.000 description 62
• 239000008194 pharmaceutical composition Substances 0.000 description 18
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 17
• 235000001014 amino acid Nutrition 0.000 description 15
• 150000001413 amino acids Chemical class 0.000 description 15
• 125000003275 alpha amino acid group Chemical group 0.000 description 13
• DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Natural products NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 6
• 239000004471 Glycine Substances 0.000 description 6
• 235000004279 alanine Nutrition 0.000 description 6
• 125000003295 alanine group Chemical group N[C@@H](C)C(=O)* 0.000 description 6
• 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 description 6
• HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 6
• 125000000487 histidyl group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 description 6
• 108090000190 Thrombin Proteins 0.000 description 4
• 230000001404 mediated effect Effects 0.000 description 4
• 229960004072 thrombin Drugs 0.000 description 4
• 230000004913 activation Effects 0.000 description 3
• 238000000034 method Methods 0.000 description 3
• SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 2
• 108090000201 Carboxypeptidase B2 Proteins 0.000 description 2
• 102100035023 Carboxypeptidase B2 Human genes 0.000 description 2
• 229920001287 Chondroitin sulfate Polymers 0.000 description 2
• 102000012545 EGF-like domains Human genes 0.000 description 2
• 108050002150 EGF-like domains Proteins 0.000 description 2
• WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
• ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
• 230000004989 O-glycosylation Effects 0.000 description 2
• 108091005804 Peptidases Proteins 0.000 description 2
• 239000004365 Protease Substances 0.000 description 2
• 101800004937 Protein C Proteins 0.000 description 2
• 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 2
• 102100036546 Salivary acidic proline-rich phosphoprotein 1/2 Human genes 0.000 description 2
• 101800001700 Saposin-D Proteins 0.000 description 2
• KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 2
• 235000003704 aspartic acid Nutrition 0.000 description 2
• CKLJMWTZIZZHCS-REOHCLBHSA-N aspartic acid group Chemical group N[C@@H](CC(=O)O)C(=O)O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
• OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 2
• 229940059329 chondroitin sulfate Drugs 0.000 description 2
• 238000003776 cleavage reaction Methods 0.000 description 2
• 235000013922 glutamic acid Nutrition 0.000 description 2
• 239000004220 glutamic acid Substances 0.000 description 2
• 125000000291 glutamic acid group Chemical group N[C@@H](CCC(O)=O)C(=O)* 0.000 description 2
• 229930182817 methionine Natural products 0.000 description 2
• 125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 description 2
• 230000003647 oxidation Effects 0.000 description 2
• 238000007254 oxidation reaction Methods 0.000 description 2
• 229960000856 protein c Drugs 0.000 description 2
• 230000007017 scission Effects 0.000 description 2
• 239000004474 valine Substances 0.000 description 2
• 125000002987 valine group Chemical group [H]N([H])C([H])(C(*)=O)C([H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
• 241001519451 Abramis brama Species 0.000 description 1
• ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
• 208000007536 Thrombosis Diseases 0.000 description 1
• 230000000694 effects Effects 0.000 description 1
• 125000003147 glycosyl group Chemical group 0.000 description 1
• 238000011905 homologation Methods 0.000 description 1
• 238000001727 in vivo Methods 0.000 description 1
• 125000001909 leucine group Chemical group [H]N(*)C(C(*)=O)C([H])([H])C(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
• 102000040430 polynucleotide Human genes 0.000 description 1
• 108091033319 polynucleotide Proteins 0.000 description 1
• 239000002157 polynucleotide Substances 0.000 description 1